Women's Health Archive

Menopausal hot flashes and night sweats, called vasomotor symptoms, are linked in research to higher odds of dementia and cardiovascular disease. But studies don't necessarily account for other health and lifestyle factors that influence brain and heart health. Women who are physically active and have a lower body mass index are less likely to become cognitively impaired. Disrupted sleep, which is common for women with vasomotor symptoms, may also contribute to cardiovascular and cognitive problems.

Using hormone therapy, which involves taking estrogen and sometimes progesterone, doesn't stop or slow the approach of menopause. The arrival of menopause is determined by women's ovaries, not by the amount of these hormones in the body.

Studies show that women's pain experiences are often minimized, dismissed, or undertreated by clinicians. Women and men perceive pain differently. Factors contributing to women's undertreatment for pain include lack of objective pain measures, uncertain diagnoses, clinician bias, and how women are socialized. Women can ensure their pain is taken seriously by communicating closely with clinicians about expectations, stating they recognize their pain may not be 100% relieved, and doing their own research on possible reasons for pain.

A 2025 research review suggested that women with certain gynecological disorders, such as polycystic ovary syndrome, endometriosis, heavy periods, and irregular menstrual cycles, have higher risks of cardiovascular and cerebrovascular disease.

Women receive less information about perimenopause compared with the earlier milestones of puberty and pregnancy. Some women deal with an array of symptoms they don't connect to perimenopause and aren't aware that lifestyle changes can offset them. The menopause transition often involves weight gain from both shifting hormones and aging. Regular exercise and strength training can mitigate weight gain. Healthy eating habits and sounder sleep can also offset perimenopausal symptoms.

Women officially reach menopause a year after periods end. Any vaginal bleeding after menopause should be evaluated. Bleeding can come from vaginal dryness or atrophy, medication side effects, various infections, endometrial thickening, or cancer.

The FDA added a boxed warning in December 2024 to fezolinetant (Veozah), a nonhormonal drug that reduces hot flashes and night sweats in menopausal women. The drug may cause rare but serious liver injury.

An estimated six in 10 women will at some point experience symptoms from pelvic floor weakness. Risk factors include pregnancy (especially with vaginal delivery), chronic constipation, family history, smoking, aging, menopause, obesity, chronic coughing, and occupations involving heavy lifting. Women with pelvic floor weakness may experience signs such as leaking urine, having trouble using a tampon, being unable to fully empty their bladder or rectum, and feeling a bulge in their vagina.